Office Action Predictor
Last updated: April 16, 2026
Application No. 19/043,052

INTERVERTEBRAL IMPLANT HAVING VARIABLE HEIGHT SERRATIONS

Non-Final OA §102§103
Filed
Jan 31, 2025
Examiner
ROBERT, EDUARDO C
Art Unit
3773
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Additive Implants, INC.
OA Round
1 (Non-Final)
22%
Grant Probability
At Risk
1-2
OA Rounds
3y 2m
To Grant
36%
With Interview

Examiner Intelligence

Grants only 22% of cases
22%
Career Allow Rate
21 granted / 95 resolved
-47.9% vs TC avg
Moderate +14% lift
Without
With
+13.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
5 currently pending
Career history
100
Total Applications
across all art units

Statute-Specific Performance

§101
3.9%
-36.1% vs TC avg
§103
39.5%
-0.5% vs TC avg
§102
30.7%
-9.3% vs TC avg
§112
20.6%
-19.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 95 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Drawings The drawings are objected to because of the following: Figures 1-10 are not legible. They appear to be photocopies (rather than clear, black-line drawings), are dark and with poor contrast, they are illegible and fail to clearly disclose the invention as required by 37 CFR 1.84 and MPEP guidance. The drawings are objected to as failing to comply with 37 CFR 1.84(p)(5) because they do not include the following reference sign(s) mentioned in the description: “210” (see applicant’s specification, paragraph [0071]. The drawings are objected to as failing to comply with 37 CFR 1.84(p)(5) because they include the following reference character(s) not mentioned in the description: “215” (Figures 9-10); “22” (Figure 3); “115” (Figure 6); “315” (Figure 11). Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Specification The disclosure is objected to because of the following informalities: In paragraph [0071], line 4, “FIG. 6 “ should be changed to -- FIGS. 9-10 --. The description presented in paragraph [0071] is for the embodiment of Figures 9-10. Reference number “110” has been used to identify different parts, i.e. “implant” and “serrations”. Reference number “102” has been used to identify different parts, i.e. “serrations”, “surface architectures” and “anterior side”. Reference number “300” has been used to identify different parts, i.e. “sagittal inclination”, “angle” and “device”. Appropriate correction is required. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1 and 7 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Ehteshami (Pub. No.: US 2020/0197050 A1). With regard to claim 1, Ehteshami discloses an intervertebral implant for implantation in an intervertebral space between vertebrae (see annotated Figure 4 below). The implant comprising a body 102 extending from an upper surface 110 to a lower surface 112, the body 102 having an anterior end 114, a posterior end 116, and a pair of spaced apart first and second side walls 118, 120 (see Figure 5) extending between the anterior end 114 and the posterior end 116. An internal chamber 136 is defined within the anterior and posterior ends 114, 116 and the first and second side walls 118, 120. The body 102 further includes a porous structure, i.e. multiple holes (for example holes 122, 124, 126, 132 and 134 that intersect within the body 102 to form internal chamber 136, see specification paragraph [0052]) configured to receive bone graft material. Also, the body includes other holes, e.g. 150, that received a porous structure (see specification, paragraph [0057]). As shown in annotated Figure 4, below, the upper surface 110 further comprising a plurality of upper serrations 144 positioned such that the serrations are angled and directed toward the posterior end of the body, wherein the plurality of upper serrations 144 has different heights above the upper surface (see serrations 144, on the upper surface 110, having different heights). The lower surface 112 further comprising a plurality of lower serrations 144 positioned such that the serrations are angled and directed toward the anterior end of the body, wherein the plurality of lower serrations has different heights above the lower surface (see annotated Figure 4 below). PNG media_image1.png 569 1153 media_image1.png Greyscale With regard to claim 7, the plurality of upper serrations 144 gradually increase in height along the posterior to anterior direction (e.g. annotated Figure 4, shown above, shows the posterior-most serration’s height being lower than the anterior-most serration’s height). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 8-11 are rejected under 35 U.S.C. 103 as being unpatentable over Ehteshami (Pub. No.: US 2020/0197050 A1). Ehteshami discloses that the plurality of upper and lower serrations may modified as appropriate for different approaches to the spine, different spinal levels, and/or different treatment modalities (see specification, paragraph [0056] and further discloses substituting serrations with barbs, teeth, spikes, or similar features. Ehteshami discloses the claim invention except for the plurality of upper serrations gradually increasing or varying in height by 50% or greater along the posterior to anterior direction (claims 8 and 9); an anterior- most serration having a height that is at least 50% greater than the height of a posterior-most serration (claim 10); and the anterior-most serration having a height that is twice the height of the posterior-most serration (claim 11). It would have been obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to modify Ehteshami’s serration geometry to achieve the recited height differentials. Surgeons and implant designers routinely tailor serration profiles to improve engagement with vertebral anatomy and to resist migration under anteriorly directed forces; accordingly, increasing serration height toward the anterior portion of the device is a predictable, design-driven modification. Where the general conditions of a claim are disclosed in the prior art, selecting an optimum or workable range is a matter of routine optimization within the skill of the art. See In re Aller, 220 F.2d 454, 105 USPQ 233 (CCPA 1955). Thus, implementing a 50% or greater increase in serration height in the posterior-to-anterior direction, an anterior-most serration at least 50% greater than a posterior-most serration, or an anterior-most serration twice the height of a posterior-most serration would have been within the ordinary skill of the art and would have yielded predictable results without invention. Allowable Subject Matter Claims 12-20 are allowed. Claims 2-6 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Reasons for Allowance The following is a statement of reasons for the indication of allowable subject matter: The claims in the instant application have not been rejected using prior art because no references, or reasonable combination thereof, could be found which disclose, or suggest, an intervertebral implant as set forth in claims 12 and 17, wherein the upper serrations rise from the upper surface at a 45-degree angle and each of the plurality of upper serrations have different heights above the upper surface, and wherein each of the plurality of lower serrations extends from the lower surface at a 60-degree angle and are directed toward the anterior end of the body. The claims in the instant application have not been rejected using prior art because no reference, or reasonable combination thereof, could be found which disclose, or suggest, an intervertebral implant as set forth in claims 2 and 5, wherein the plurality of lower serrations gradually increase in height along the anterior to posterior direction. The claims in the instant application have not been rejected using prior art because no reference, or reasonable combination thereof, could be found which disclose, or suggest, an intervertebral implant as set forth in claim 3, wherein the plurality of lower serrations gradually increase in height by 50% or greater along the anterior to posterior direction. The claims in the instant application have not been rejected using prior art because no reference, or reasonable combination thereof, could be found which disclose, or suggest, an intervertebral implant as set forth in claim 4, wherein the plurality of lower serrations have a variation of height along the anterior to posterior direction by 50% or greater. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See PTO-892 for recited art of interest. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eduardo C Robert whose telephone number is (571)272-4719. The examiner can normally be reached M-F: 8 AM-4:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Edward Lefkowitz can be reached at 571-272-2180. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /EDUARDO C ROBERT/Supervisory Patent Examiner, Art Unit 3773
Read full office action

Prosecution Timeline

Jan 31, 2025
Application Filed
Nov 05, 2025
Non-Final Rejection — §102, §103
Mar 29, 2026
Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12588918
INVERTING CAPTURE APPARATUSES HAVING MATERIAL DEPOTS
2y 5m to grant Granted Mar 31, 2026
Patent 12589009
EXPANDABLE FUSION DEVICE WITH INTEGRATED DEPLOYABLE RETENTION SPIKES
2y 5m to grant Granted Mar 31, 2026
Patent 12539132
TISSUE RESECTING INSTRUMENT
2y 5m to grant Granted Feb 03, 2026
Patent 12433758
EXPANDABLE SPINAL IMPLANT
2y 5m to grant Granted Oct 07, 2025
Patent 12390340
INTERSPINOUS SPACER WITH A RANGE OF DEPLOYMENT POSITIONS AND METHODS AND SYSTEMS
2y 5m to grant Granted Aug 19, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
22%
Grant Probability
36%
With Interview (+13.9%)
3y 2m
Median Time to Grant
Low
PTA Risk
Based on 95 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month